Moffitt logo

Clinical Trials Search

Search Results:

Showing of 50

CLINICAL TRIAL 20845

Health Insurance Literacy in Head and Neck Cancer Patients

Cancer Type: Head & Neck

View Trial Details

CLINICAL TRIAL 18994

Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing

Cancer Type: Head & Neck

View Trial Details

CLINICAL TRIAL 20144

A Phase 1, First-in-Human, Open-Label, Dose Escalation and Expansion Study of CUE-101 Monotherapy in Second Line and CUE-101 Combination Therapy with Pembrolizumab in First Line Patients with HPV16+ Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Cancer Type: Head & Neck

View Trial Details

CLINICAL TRIAL 19748

Phase II Randomized Trial of Radiotherapy with Concurrent and Adjuvant Pembrolizumab (Keytruda®) Versus Concurrent Chemotherapy in Patients with Advanced/Intermediate-Risk p16+ Head and Neck Squamous Cell Carcinoma (KEYCHAIN Trial)

Cancer Type: Head & Neck

View Trial Details

CLINICAL TRIAL 21079

Head and Neck Cancer Pre-Surgery Education and Discharge Planning: Key Stakeholder Perceptions

Cancer Type: Head & Neck

View Trial Details

CLINICAL TRIAL 19855

The AIM-HN and SEQ-HN Study: A 2 Cohort, Non-comparative, Pivotal Study Evaluating the Efficacy of Tipifarnib in Patients with Head and Neck Squamous Cell Carcinoma(HNSCC) with HRAS Mutations (AIM-HN) and the Impact of HRAS Mutations on Response to First Line Systemic Therapies for HNSCC (SEQ-HN)

Cancer Type: Head & Neck

View Trial Details

CLINICAL TRIAL 20485

A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment

Cancer Type: Head & Neck

View Trial Details

CLINICAL TRIAL 20490

Keystroke: A Randomized Phase II Study of Pembrolizumab (Keytruda) Plus Stereotactic Re-irradiation versus SBRT Alone For Locoregionally Recurrent or Second Primary Head and Neck Carcinoma

Cancer Type: Head & Neck

View Trial Details

CLINICAL TRIAL 19473

Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin

Cancer Type: Head & Neck

View Trial Details

CLINICAL TRIAL 19356

A Phase 1b Trial of the IRX-2 Regimen and Durvalumab (MEDI4736), in Patients with Incurable Head and Neck Squamous Cell Carcinoma

Cancer Type: Head & Neck

View Trial Details

CLINICAL TRIAL 19570

A Phase II Trial of Pembrolizumab and Cabozantinib in Patients with RM SCCHN

Cancer Type: Head & Neck

View Trial Details

CLINICAL TRIAL 17716

A Biomarker-related Approach to Screening for HPV-related Oropharyngeal Cancer

Cancer Type: Head & Neck

View Trial Details

CLINICAL TRIAL 20270

A Phase 2, Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-144 or LN-145) in Patients with Solid Tumors (IOV-COM-202)

Cancer Type: Immunotherapy

View Trial Details

CLINICAL TRIAL 20123

A Dose-Optimization, Exploratory Phase Ib/II Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143, When Given in Combination with the Anti-PD-1 Antibody Nivolumab in Patients with Specific Solid Tumors who have Progressed During or Immediately after anti-PD-1/PD-L1 Treatment

Cancer Type: Multiple

View Trial Details